title: Thymic neuroendocrine carcinoma presenting as cushing's syndrome: treatment with octreotide combined with surgery and radiotherapy.
authors.affiliation: Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey.
authors.forename: Ebru
authors.initials: E
authors.lastname: Asicioglu
authors.forename: Gokhan
authors.initials: G
authors.lastname: Gonenli
authors.forename: Arzu
authors.initials: A
authors.lastname: Kahveci
authors.forename: Bedrettin
authors.initials: B
authors.lastname: Yildizeli
authors.forename: Oguzhan
authors.initials: O
authors.lastname: Deyneli
authors.forename: Dilek
authors.initials: D
authors.lastname: Yavuz
authors.forename: Mustafa
authors.initials: M
authors.lastname: Yuksel
authors.forename: Sema
authors.initials: S
authors.lastname: Akalin
mesh_terms: D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003480:Cushing Syndrome / Q000628:therapy*; D005260:Female; D006801:Humans; D018358:Neuroendocrine Tumors / Q000628:therapy*; D015282:Octreotide / Q000627:therapeutic use*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000628:therapy*; D020266:Radiotherapy, Conformal; D013953:Thymus Neoplasms / Q000628:therapy*; D013965:Thyroidectomy; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide